Kuros Biosciences Logo

Kuros Biosciences

🇨🇭
KURN
CH0325814116

Kuros Biosciences, headquartered in Switzerland, is a leading biopharmaceutical company specializing in innovative bone graft substitutes. By developing advanced technologies for orthopedic surgery, Kuros Biosciences is dedicated to optimizing bone healing processes and patient outcomes worldwide.

Next Quarterly Earnings

Tuesday, March 9, 2027
Expected

Stock Price

Frequently asked questions

When did Kuros Biosciences last report quarterly earnings?

Kuros Biosciences last reported quarterly earnings on 10/15/2026 (Q3 2026).

How does Kuros Biosciences stock react to earnings?

Across its last 4 earnings reports, Kuros Biosciences stock moved by ±4% on average the following day. The largest reaction was +10.6% on 03/10/2026; 3 of 4 reactions were positive.

How do I add the Kuros Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:—
Actual:—
Price reaction (1 day):-2.0 %
Q2 2026
Beat
Estimate:CHF 0.06
Actual:CHF 0.06
Difference:+CHF 0.00
Price reaction (1 day):+0.6 %
Price reaction (7 days):-2.4 %
Q1 2026
Estimate:—
Actual:—
Price reaction (1 day):+2.9 %
Price reaction (7 days):-8.4 %
Q4 2025
Estimate:—
Actual:CHF 0.05
Price reaction (1 day):+10.6 %
Price reaction (7 days):-12.3 %

Earnings statistics

Stock reaction to earnings

±4%
Avg. next-day move
+10.6%
Largest move (03/10/2026)
75%
Share of positive reactions
±7.7%
Avg. move after 7 days

Basis: price reactions to the last 4 report dates (close to close).

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Kuros Biosciences
Ticker Symbol
KURN
ISIN
CH0325814116
Country
🇨🇭
Switzerland
Sector